Drug detection test kit RIDASCREEN®

serumplasmaELISA

The RIDASCREEN® UST Monitoring is an enzyme linked immunosorbent assay intended for the quantitative determination of ustekinumab (UST, Stelara®) in human serum and plasma. Product information Ustekinumab (UST, Stelara®) is a fully human monoclonal antibody that binds to the p40 subunit common to IL-12 and IL-23 thereby preventing the interaction with the cytokine receptors on T cells, natural killer cells and antigen-presenting cells.UST has been approved for treatment of moderate to severe Crohn’s disease (CD), plaque psoriasis and psoriatic arthritis. The RIDASCREEN® UST Monitoring and our other TDM assays are vital to personalize treatment of patients to achieve better therapeutic targets. Key features: CE-marked version of the ELISA tests of KU Leuven Highly specific antibodies Ready to use reagents Validated for use on automated ELISA systems, e.g. the Dynex DSX®